ARCT - Arcturus Therapeutics EPS of $4.33 revenue of $160.29M beats by $79.77M March, 28 2023 04:02 PM Arcturus Therapeutics Ltd. 2023-03-28 16:02:10 ET Arcturus Therapeutics press release ( NASDAQ: ARCT ): Q4 EPS of $4.33 may not be comparable to consensus of $1.23. Revenue of $160.29M (+2663.6% Y/Y) beats by $79.77M . For further details see: Arcturus Therapeutics EPS of $4.33, revenue of $160.29M beats by $79.77M